A Profile and Three-Year Follow-Up of Patients with Basal Cell Carcinoma in the Western Cape, South Africa

Table 3

NCCN risk stratification and final treatment modalities for BCC lesions (N = 246).

Treatment modality, n (%)	Total high- and low-risk (N = 246)	Risk stratification
		High-risk (n = 135)	Low-risk (n = 111)
Excision by plastic and reconstructive surgery	182 (74.0)	109 (44.3) (3)	73 (29.7) (3)
Double-cycle C&E at dermatology	37 (15.0)	18 (7.3)	19 (7.7) (2)
Excision at dermatology	19 (7.7)	4 (1.6)	15 (6.1)
Other treatments	3 (1.2)	2 (0.8) (1)	1 (0.4)
Loss to follow-up	5 (2.0)	2 (0.8)	3 (1.2)

(n) represents the number of recurrent cases in a specific treatment modality.